Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-22 Sale | 2026-04-23 4:02 pm | BioNTech SE | BNTX | Poetting Sierk Chief Operating Officer | 50,000 | $110.56 | $5,527,960 | 399,387 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-12 Option Award | 2026-05-13 4:09 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Zapata Gomez Ramon Chief Financial Officer | 33,982 | $0 | 33,982 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:07 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Ryan James Timothy Patrick See remarks. | 22,655 | $0 | 22,655 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:05 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Poetting Sierk Chief Operating Officer | 22,655 | $0 | 22,655 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:03 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Jimenez Kylie Chief People Officer | 18,879 | $0 | 18,879 (Direct) | View |
| 2026-05-12 Option Award | 2026-05-13 4:02 pm | 2030-05-12 2036-05-12 | BioNTech SE | BNTX | Hanekamp Annemarie Chief Commercial Officer | 22,655 | $0 | 22,655 (Direct) | View |
Ownership(A) | 2026-04-13 4:02 pm | N/A N/A | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 0 | $0 | 39,218,111 (Indirect) | View |
Ownership | 2026-03-25 6:03 pm | N/A N/A | BioNTech SE | BNTX | Morawietz Anja Director | 0 | $0 | 240 (Direct) | View |
Ownership | 2026-03-25 6:01 pm | N/A N/A | BioNTech SE | BNTX | Staudigl Rudolf Director | 0 | $0 | 400 (Direct) | View |
Ownership | 2026-03-25 6:00 pm | N/A N/A | BioNTech SE | BNTX | Sahin Ugur Chief Executive Officer 10% Owner | 0 | $0 | 41,162,694 (Indirect) | View |
Ownership | 2026-03-25 5:57 pm | N/A N/A | BioNTech SE | BNTX | Ryan James Timothy Patrick See remarks. | 0 | $0 | 51,629 (Direct) | View |
Ownership | 2026-03-18 5:41 pm | N/A N/A | BioNTech SE | BNTX | Poetting Sierk Chief Operating Officer | 0 | $0 | 678,075 (Indirect) | View |
Ownership | 2026-03-18 5:39 pm | N/A N/A | BioNTech SE | BNTX | Jeggle Helmut Wolfgang Director | 0 | $0 | 989,267 (Direct) | View |
Ownership | 2026-03-18 5:36 pm | 2027-05-22 2033-05-22 | BioNTech SE | BNTX | Tureci Ozlem Chief Medical Officer | 0 | $0 | 86,590 (Direct) | View |
Ownership | 2026-03-18 5:33 pm | N/A N/A | BioNTech SE | BNTX | Wandschneider Ulrich Director | 0 | $0 | 1,927 (Indirect) | View |
Ownership | 2026-03-18 5:30 pm | 2029-05-28 2035-05-28 | BioNTech SE | BNTX | Hanekamp Annemarie Chief Commercial Officer | 0 | $0 | 19,885 (Direct) | View |